These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 725323)

  • 21. Role of amino acid depletion in combined treatment of neoplastic cells with methotrexate and L-asparaginase.
    Chlopkiewicz B; Koziorowska J
    Cancer Res; 1975 Jun; 35(6):1524-9. PubMed ID: 805660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of melphalan by sensitive and resistant L1210 cells.
    Redwood WR; Colvin M
    Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545
    [No Abstract]   [Full Text] [Related]  

  • 23. [Asparaginase and glutaminase activity in Pseudomonas fluorescens in continuous cultivation].
    Eremenko VV; Zhukov AV; Nikolaev AIa
    Mikrobiologiia; 1975; 44(4):615-20. PubMed ID: 809640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutaminase induced prolonged regression of established Ehrlich carcinoma.
    Roberts J; Holcenberg JS; Dolowy WC
    Life Sci II; 1971 Mar; 10(5):251-5. PubMed ID: 4930322
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal chemotherapy with melphalan plus glutaminase.
    Holcenberg J; Anderson T; Ritch P; Skibba J; Howser D; Ring B; Adams S; Helmsworth M
    Cancer Res; 1983 Mar; 43(3):1381-8. PubMed ID: 6825107
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induced formation of asparagine- and glutamine synthetases by Pseudomonas sp].
    Evseev LP; Nikolaev AIa
    Biokhimiia; 1968; 33(5):1106-10. PubMed ID: 5703741
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS; Camitta BM; Borella LD; Ring BJ
    Cancer Treat Rep; 1979 Jun; 63(6):1025-30. PubMed ID: 380800
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of amphotericin B on adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia.
    Ozols RF; Hogan WM; Grotzinger KR; McCoy W; Young RC
    Cancer Res; 1983 Mar; 43(3):959-64. PubMed ID: 6825115
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.
    Holcenberg JS; Borella LD; Camitta BM; Ring BJ
    Cancer Res; 1979 Aug; 39(8):3145-51. PubMed ID: 455299
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction of asparaginase and glutaminase activities in Pseudomonas sp. with asparaginic and glutamic acids].
    Mardashev SR; Nikolaev AIa; Evseev LP; Eremenko VV
    Biokhimiia; 1967; 32(5):1093-8. PubMed ID: 5599896
    [No Abstract]   [Full Text] [Related]  

  • 34. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
    Kuin A; Aalders M; Lamfers M; van Zuidam DJ; Essers M; Beijnen JH; Smets LA
    Br J Cancer; 1999 Feb; 79(5-6):793-801. PubMed ID: 10070871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
    Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and properties of L-glutaminase-L-asparaginase from Pseudomonas acidovorans.
    Davidson L; Brear DR; Wingard P; Hawkins J; Kitto GB
    J Bacteriol; 1977 Mar; 129(3):1379-86. PubMed ID: 845119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
    Maity P; Chakraborty S; Bhattacharya P
    J Exp Clin Cancer Res; 2000 Jun; 19(2):161-4. PubMed ID: 10965812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid degrading enzymes for cancer therapy.
    Wade HE
    Dev Biol Stand; 1977 Apr 13-15; 38():73-9. PubMed ID: 415922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.